Questions for Your Health Care Team

You are the most important person on your health care team. Other important members of your health care team include your doctor, dietitian, nurse, pharmacist, and/or social worker.

If you have secondary HPT, there are many questions you can ask your health care team to learn more about the disease and your treatment options:

What are my treatment options for secondary HPT?
What are the benefits and side effects of these treatments?
Is Sensipar^® right for me?
What can I do to keep my lab values balanced?
What are my recommended lab goals?
What is the best diet for me?
I need help paying for my medicines. What options are available?

Sensipar^® is indicated for the treatment of secondary hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) on dialysis.

Important Safety Information

Sensipar^® treatment should not be started if you have low calcium levels. Ask your doctor about the normal ranges.
Before starting Sensipar^®, tell your doctor if you are taking medication to prevent seizures or have had seizures in the past. Report any seizure episodes while on Sensipar^® therapy.
Very infrequent cases of low blood pressure, worsening heart failure, and/or abnormal heart rhythm (arrhythmia) have been reported in patients with impaired heart function taking Sensipar^®.
While on Sensipar^®, your doctor should perform repeated blood tests to monitor calcium, phosphorus, and intact parathyroid hormone (iPTH) levels. Very low and very high levels of PTH should be avoided to help maintain bone health. Very low levels (iPTH < 100 pg/mL) of PTH may cause a condition your doctor may refer to as adynamic bone disease.
Patients with moderate to severe liver impairment should be monitored throughout treatment with Sensipar^®.
Tell your doctor if you experience any muscle spasms, aches or cramping, tingling in your limbs, or seizures.
In clinical trials, the most common side effects reported in patients were nausea, vomiting, and diarrhea. If you have any questions about this information, be sure to discuss them with your doctor.

This site is intended for a US audience only.

Prescribing Information | Important Safety Information | General Conformity Certificates
Terms of Use | Privacy Statement